Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anne-Marie Feeney
Institutions:
Dana-Farber Cancer Institute,
Dana-Farber Brigham Cancer Center
Observed institutions:
Brigham and Women's Hospital,
Dana-Farber Cancer Institute,
Dana-Farber/Harvard Cancer Center,
Dana-Farber Brigham Cancer Center,
Stanford University
ORCID:
0009-0008-9468-1746
Observed ORCID:
0009-0008-9468-1746
OpenAlex ID:
A5035326269
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
2023
·
Paolo Tarantino
, Hersh Gupta
, et al.
·
Nature Communications
·
64
PDF
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression
2023
·
Jun Nishida
, Simona Cristea
, et al.
·
Proceedings of the National Academy of Sciences
·
11
Clinicogenomic Characterization of Inflammatory Breast Cancer
2025
·
Nolan Priedigkeit
, Beth Harrison
, et al.
·
Clinical Cancer Research
·
5
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer
2023
·
Paolo Tarantino
, Hersh Gupta
, et al.
·
Nature Communications
·
3
PDF
Abstract HER2-05: HER2-05 Comprehensive genomic characterization of HER2-low breast cancer
2023
·
Paolo Tarantino
, Hersh V. Gupta
, et al.
·
Cancer Research
·
3
Tumor genomics in patients younger than 40 years of age with metastatic breast cancer
2026
·
Kristen D. Brantley
, Ananya Kodali
, et al.
·
npj Precision Oncology
·
1
PDF
Epco-45. Single-cell Landscape of B7h3-car T Therapy in Glioma: Mechanisms of Resistance and Signatures of Long-term Response
2025
·
Yiyun Chen
, Kun-Wei Song
, et al.
·
Neuro-Oncology
Data from Clinicogenomic Characterization of Inflammatory Breast Cancer
2025
·
Nolan Priedigkeit
, Beth Harrison
, et al.
Supplementary Figure S4 from Clinicogenomic Characterization of Inflammatory Breast Cancer
2025
·
Nolan Priedigkeit
, Beth Harrison
, et al.
PDF
Supplementary Figure S3 from Clinicogenomic Characterization of Inflammatory Breast Cancer
2025
·
Nolan Priedigkeit
, Beth Harrison
, et al.
PDF
Supplementary Figure S2 from Clinicogenomic Characterization of Inflammatory Breast Cancer
2025
·
Nolan Priedigkeit
, Beth Harrison
, et al.
PDF
Supplementary Figure S1 from Clinicogenomic Characterization of Inflammatory Breast Cancer
2025
·
Nolan Priedigkeit
, Beth Harrison
, et al.
PDF
Supplementary Tables S1-S15 from Clinicogenomic Characterization of Inflammatory Breast Cancer
2025
·
Nolan Priedigkeit
, Beth Harrison
, et al.
Abstract P3-09-19: Tumor genomics in young patients with metastatic breast cancer
2025
·
Kristen Brantley
, Ananya Kodali
, et al.
·
Clinical Cancer Research
Abstract PO1-14-10: Comprehensive clinicogenomic characterization of inflammatory breast cancer
2024
·
Nolan Priedigkeit
, Beth Harrison
, et al.
·
Cancer Research
Abstract PD7-07: Somatic alterations in primary tumors of patients (pts) with metastatic breast cancer (MBC) may predict likelihood of brain metastasis
2023
·
Sheheryar Kabraji
, Yvonne Y. Li
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
87
H-index:
3
I10-index:
2
Year
Topic
Type